EUCTR2007-004271-19-HU
进行中（未招募）
不适用
A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-ControlledStudy to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure. - RELAX-AHF
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Corthera, Inc.
- 入组人数
- 1160
- 状态
- 进行中（未招募）
- 最后更新
- 13年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •\- Hospitalized for acute heart failure
- •\- Dyspnea at rest or with minimal exertion
- •\- Pulmonary congestion
- •\- Able to provide informed consent
- •\- Systolic blood pressure \> 125 mmHg
- •\- Impaired renal function defined as an eGFR of 30\-75 mL/min/1\.73m2
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
排除标准
- •\- Use of other IV therapies for acute heart failure
- •\- Fever or sepsis
- •\- Recent major neurologic event
- •\- Recent major surgery
- •\- Recent acute coronary syndrome
- •\- Other recent investigational drug use
结局指标
主要结局
未指定
相似试验
进行中（未招募）
1 期
A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure.EUCTR2007-004271-19-NLCorthera, Inc.
进行中（未招募）
1 期
A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure.Estudio de fase II/III, multicéntrico, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia y la seguridad de relaxina en sujetos con insuficiencia cardíaca aguda - RELAX-AHFPatients hospitalized with Acute Heart Failure (AHF), normal to elevated blood pressure, and mild to moderate renal impairment. Pacientes hospitalizados con insuficiencia cardíaca aguda (ICA), presión arterial normal o elevada y disfunción renal leve o moderadaMedDRA version: 9.1Level: LLTClassification code 10000803Term: Acute heart failureEUCTR2007-004271-19-ESCorthera, Inc.
进行中（未招募）
1 期
A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure.Patients hospitalized with Acute Heart Failure (AHF), normal to elevated blood pressure, and mild to moderate renal impairment.MedDRA version: 14.1 Level: LLT Classification code 10000803 Term: Acute heart failure System Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2007-004271-19-GBCorthera, Inc.
进行中（未招募）
不适用
A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure.Patients hospitalized with Acute Heart Failure (AHF), normal to elevated blood pressure, and mild to moderate renal impairment.MedDRA version: 14.1Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2007-004271-19-DECorthera, Inc.1,160
进行中（未招募）
1 期
A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-ControlledStudy to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure. - RELAX-AHFPatients hospitalized with Acute Heart Failure (AHF), normal to elevated blood pressure, and mild to moderate renal impairment.MedDRA version: 9.1Level: LLTClassification code 10000803Term: Acute heart failureEUCTR2007-004271-19-FRCorthera, Inc.